904 related articles for article (PubMed ID: 10766989)
1. Dual-probe fluorescence in situ hybridization assay for detecting deletions associated with VCFS/DiGeorge syndrome I and DiGeorge syndrome II loci.
Berend SA; Spikes AS; Kashork CD; Wu JM; Daw SC; Scambler PJ; Shaffer LG
Am J Med Genet; 2000 Apr; 91(4):313-7. PubMed ID: 10766989
[TBL] [Abstract][Full Text] [Related]
2. A common region of 10p deleted in DiGeorge and velocardiofacial syndromes.
Daw SC; Taylor C; Kraman M; Call K; Mao J; Schuffenhauer S; Meitinger T; Lipson T; Goodship J; Scambler P
Nat Genet; 1996 Aug; 13(4):458-60. PubMed ID: 8696341
[TBL] [Abstract][Full Text] [Related]
3. Chromosome 22q11.2 microdeletions in velocardiofacial syndrome patients with widely variable manifestations.
Ravnan JB; Chen E; Golabi M; Lebo RV
Am J Med Genet; 1996 Dec; 66(3):250-6. PubMed ID: 8985481
[TBL] [Abstract][Full Text] [Related]
4. Submicroscopic deletions at 22q11.2: variability of the clinical picture and delineation of a commonly deleted region.
Lindsay EA; Greenberg F; Shaffer LG; Shapira SK; Scambler PJ; Baldini A
Am J Med Genet; 1995 Mar; 56(2):191-7. PubMed ID: 7625444
[TBL] [Abstract][Full Text] [Related]
5. DiGeorge anomaly and chromosome 10p deletions: one or two loci?
Dasouki M; Jurecic V; Phillips JA; Whitlock JA; Baldini A
Am J Med Genet; 1997 Nov; 73(1):72-5. PubMed ID: 9375926
[TBL] [Abstract][Full Text] [Related]
6. Molecular and genetic aspects of DiGeorge/velocardiofacial syndrome.
Driscoll DA
Methods Mol Med; 2006; 126():43-55. PubMed ID: 16930005
[TBL] [Abstract][Full Text] [Related]
7. The phenotypic spectrum of the 10p deletion syndrome versus the classical DiGeorge syndrome.
Van Esch H; Groenen P; Fryns JP; Van de Ven W; Devriendt K
Genet Couns; 1999; 10(1):59-65. PubMed ID: 10191430
[TBL] [Abstract][Full Text] [Related]
8. Interstitial deletion of 10p and atrial septal defect in DiGeorge 2 syndrome.
Yatsenko SA; Yatsenko AN; Szigeti K; Craigen WJ; Stankiewicz P; Cheung SW; Lupski JR
Clin Genet; 2004 Aug; 66(2):128-36. PubMed ID: 15253763
[TBL] [Abstract][Full Text] [Related]
9. Microsatellite DNA markers detects 95% of chromosome 22q11 deletions.
Bonnet D; Cormier-Daire V; Kachaner J; Szezepanski I; Souillard P; Sidi D; Munnich A; Lyonnet S
Am J Med Genet; 1997 Jan; 68(2):182-4. PubMed ID: 9028455
[TBL] [Abstract][Full Text] [Related]
10. Altered replication timing of the HIRA/Tuple1 locus in the DiGeorge and Velocardiofacial syndromes.
D'Antoni S; Mattina T; Di Mare P; Federico C; Motta S; Saccone S
Gene; 2004 May; 333():111-9. PubMed ID: 15177686
[TBL] [Abstract][Full Text] [Related]
11. Patient with a 22q11.2 deletion with no overlap of the minimal DiGeorge syndrome critical region (MDGCR).
McQuade L; Christodoulou J; Budarf M; Sachdev R; Wilson M; Emanuel B; Colley A
Am J Med Genet; 1999 Sep; 86(1):27-33. PubMed ID: 10440825
[TBL] [Abstract][Full Text] [Related]
12. Velo-cardio-facial syndrome: frequency and extent of 22q11 deletions.
Lindsay EA; Goldberg R; Jurecic V; Morrow B; Carlson C; Kucherlapati RS; Shprintzen RJ; Baldini A
Am J Med Genet; 1995 Jul; 57(3):514-22. PubMed ID: 7677167
[TBL] [Abstract][Full Text] [Related]
13. DiGeorge syndrome and partial monosomy 10p: case report and review.
Schuffenhauer S; Seidel H; Oechsler H; Belohradsky B; Bernsau U; Murken J; Meitinger T
Ann Genet; 1995; 38(3):162-7. PubMed ID: 8540688
[TBL] [Abstract][Full Text] [Related]
14. Confirmation that the velo-cardio-facial syndrome is associated with haplo-insufficiency of genes at chromosome 22q11.
Kelly D; Goldberg R; Wilson D; Lindsay E; Carey A; Goodship J; Burn J; Cross I; Shprintzen RJ; Scambler PJ
Am J Med Genet; 1993 Feb; 45(3):308-12. PubMed ID: 8434616
[TBL] [Abstract][Full Text] [Related]
15. [Clinical heterogeneity of the chromosome 22q11 microdeletion syndrome].
Muñoz S; Garay F; Flores I; Heusser F; Talesnik E; Aracena M; Mellado C; Méndez C; Arnaiz P; Repetto G
Rev Med Chil; 2001 May; 129(5):515-21. PubMed ID: 11464533
[TBL] [Abstract][Full Text] [Related]
16. Deletion mapping on chromosome 10p and definition of a critical region for the second DiGeorge syndrome locus (DGS2).
Schuffenhauer S; Lichtner P; Peykar-Derakhshandeh P; Murken J; Haas OA; Back E; Wolff G; Zabel B; Barisic I; Rauch A; Borochowitz Z; Dallapiccola B; Ross M; Meitinger T
Eur J Hum Genet; 1998; 6(3):213-25. PubMed ID: 9781025
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of a novel gene from the DiGeorge chromosomal region that encodes for a mediator subunit.
Berti L; Mittler G; Przemeck GK; Stelzer G; Günzler B; Amati F; Conti E; Dallapiccola B; Hrabé de Angelis M; Novelli G; Meisterernst M
Genomics; 2001 Jun; 74(3):320-32. PubMed ID: 11414760
[TBL] [Abstract][Full Text] [Related]
18. Classical Noonan syndrome is not associated with deletions of 22q11.
Robin NH; Sellinger B; McDonald-McGinn D; Zackai EH; Emanuel BS; Driscoll DA
Am J Med Genet; 1995 Mar; 56(1):94-6. PubMed ID: 7747795
[TBL] [Abstract][Full Text] [Related]
19. Detection of 22q11.2 deletion among 139 patients with Di George/Velocardiofacial syndrome features.
Kitsiou-Tzeli S; Kolialexi A; Fryssira H; Galla-Voumvouraki A; Salavoura K; Kanariou M; Tsangaris GT; Kanavakis E; Mavrou A
In Vivo; 2004; 18(5):603-8. PubMed ID: 15523900
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of three diagnostic approaches (FISH, STRs and MLPA) in 30 patients with 22q11.2 deletion syndrome.
Fernández L; Lapunzina P; Arjona D; López Pajares I; García-Guereta L; Elorza D; Burgueros M; De Torres ML; Mori MA; Palomares M; García-Alix A; Delicado A
Clin Genet; 2005 Oct; 68(4):373-8. PubMed ID: 16143025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
